The L-Dopa Story: Translational Neuroscience Ante Verbum
Neurologie FMH, Kräyigenweg 85, 3074 Muri b. Bern, Switzerland
Clin. Transl. Neurosci. 2018, 2(1), 11; https://doi.org/10.1177/2514183x18765401
Submission received: 13 November 2017
/
Accepted: 19 February 2018
/
Published: 3 April 2018
Abstract
Since almost 50 years L-Dopa is the gold standard for the treatment of patients with Parkinson’s disease (PD). For the first time, a specific chemical abnormality was found in a specific brain disorder. It has been shown that the striatal dopamine (DA) content is greatly reduced in PD patients. The substitution of DA by its precursor L-dopa greatly enhanced the quality of life of PD patients.
Keywords:
Parkinson’s disease; dopamine; L-dopa; history
Share and Cite
MDPI and ACS Style
Ludin, H.-P. The L-Dopa Story: Translational Neuroscience Ante Verbum. Clin. Transl. Neurosci. 2018, 2, 11. https://doi.org/10.1177/2514183x18765401
AMA Style
Ludin H-P. The L-Dopa Story: Translational Neuroscience Ante Verbum. Clinical and Translational Neuroscience. 2018; 2(1):11. https://doi.org/10.1177/2514183x18765401
Chicago/Turabian StyleLudin, Hans-Peter. 2018. "The L-Dopa Story: Translational Neuroscience Ante Verbum" Clinical and Translational Neuroscience 2, no. 1: 11. https://doi.org/10.1177/2514183x18765401
